STOCK TITAN

[Form 4] PagerDuty, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Myomo, Inc. (MYO) – Form 144 filing: An insider has filed notice to sell up to 13,054 shares of common stock through Morgan Stanley Smith Barney. The shares are valued at an aggregate market price of $28,588.26, representing roughly 0.04 % of the company’s 35,978,922 shares outstanding. The planned sale date is 28 June 2025 on the NYSE American exchange.

The filing also discloses a prior sale by the same individual—5,743 shares sold on 6 June 2025 for gross proceeds of $17,057. The shares being offered were acquired via the vesting of 40,000 restricted stock units dated 28 June 2025. No material adverse, non-public information is known to the filer according to the required certification.

Because the proposed sale is modest in size and represents a small fraction of the float, it is unlikely to have a material impact on trading dynamics; however, investors often monitor insider activity for sentiment signals.

Myomo, Inc. (MYO) – Comunicazione Form 144: Un dirigente ha notificato la vendita di un massimo di 13.054 azioni ordinarie tramite Morgan Stanley Smith Barney. Le azioni hanno un valore complessivo di mercato di 28.588,26 $, pari a circa lo 0,04 % delle 35.978.922 azioni in circolazione della società. La vendita è prevista per il 28 giugno 2025 sulla borsa NYSE American.

La comunicazione riporta anche una vendita precedente effettuata dallo stesso soggetto: 5.743 azioni vendute il 6 giugno 2025 per un ricavo lordo di 17.057 $. Le azioni offerte sono state acquisite tramite il vesting di 40.000 unità di azioni vincolate con data 28 giugno 2025. Secondo la certificazione richiesta, il venditore non è a conoscenza di informazioni riservate rilevanti o negative.

Poiché la vendita proposta è di dimensioni contenute e rappresenta una piccola parte del flottante, è improbabile che influenzi significativamente la dinamica di mercato; tuttavia, gli investitori spesso monitorano l’attività interna come indicatore di sentiment.

Myomo, Inc. (MYO) – Presentación del Formulario 144: Un insider ha notificado la venta de hasta 13.054 acciones comunes a través de Morgan Stanley Smith Barney. Las acciones tienen un valor total de mercado de 28.588,26 $, lo que representa aproximadamente el 0,04 % de las 35.978.922 acciones en circulación de la empresa. La venta está prevista para el 28 junio 2025 en la bolsa NYSE American.

La presentación también revela una venta previa por parte del mismo individuo: 5.743 acciones vendidas el 6 junio 2025 por ingresos brutos de 17.057 $. Las acciones ofrecidas fueron adquiridas mediante el vesting de 40.000 unidades de acciones restringidas con fecha 28 junio 2025. Según la certificación requerida, el declarante no posee información confidencial adversa material.

Dado que la venta propuesta es modesta y representa una pequeña fracción del flotante, es poco probable que tenga un impacto significativo en la dinámica de negociación; sin embargo, los inversores suelen vigilar la actividad interna como señal de sentimiento.

Myomo, Inc. (MYO) – Form 144 제출: 내부자가 Morgan Stanley Smith Barney를 통해 최대 13,054주의 보통주를 매도할 예정임을 신고했습니다. 해당 주식의 총 시장 가치는 28,588.26달러로, 회사의 35,978,922주 유통 주식의 약 0.04 %에 해당합니다. 예정 매도일은 2025년 6월 28일이며, NYSE American 거래소에서 이루어질 예정입니다.

신고서에는 동일인이 이전에 5,743주2025년 6월 6일에 매도하여 총 수익 17,057달러를 올린 사실도 포함되어 있습니다. 매도 예정 주식은 2025년 6월 28일자 제한 주식 단위 40,000주의 베스팅을 통해 취득한 것입니다. 신고자는 요구된 인증에 따라 중대한 비공개 불리한 정보를 알고 있지 않다고 명시했습니다.

제안된 매도 규모가 작고 유통 주식의 일부에 불과하므로 거래 동향에 큰 영향을 미칠 가능성은 낮으나, 투자자들은 내부자 활동을 시장 심리 신호로 자주 주시합니다.

Myomo, Inc. (MYO) – Dépôt du formulaire 144 : Un initié a déposé un avis de vente pouvant atteindre 13 054 actions ordinaires via Morgan Stanley Smith Barney. La valeur totale de ces actions s’élève à 28 588,26 $, soit environ 0,04 % des 35 978 922 actions en circulation de la société. La date prévue de la vente est le 28 juin 2025 sur la bourse NYSE American.

Le dépôt révèle également une vente antérieure par la même personne : 5 743 actions vendues le 6 juin 2025 pour un produit brut de 17 057 $. Les actions proposées ont été acquises par le vesting de 40 000 unités d’actions restreintes daté du 28 juin 2025. Selon la certification requise, le déclarant ne détient aucune information confidentielle défavorable significative.

Étant donné que la vente proposée est modeste en taille et représente une faible fraction du flottant, il est peu probable qu’elle ait un impact significatif sur la dynamique du marché ; cependant, les investisseurs surveillent souvent l’activité des initiés comme indicateur de sentiment.

Myomo, Inc. (MYO) – Form 144 Einreichung: Ein Insider hat den Verkauf von bis zu 13.054 Aktien über Morgan Stanley Smith Barney gemeldet. Der Gesamtwert der Aktien beträgt 28.588,26 $ und entspricht etwa 0,04 % der 35.978.922 ausstehenden Aktien des Unternehmens. Der geplante Verkaufstermin ist der 28. Juni 2025 an der NYSE American Börse.

Die Einreichung offenbart außerdem einen früheren Verkauf derselben Person – 5.743 Aktien wurden am 6. Juni 2025 für Bruttoerlöse von 17.057 $ verkauft. Die angebotenen Aktien wurden durch das Vesting von 40.000 Restricted Stock Units mit Datum 28. Juni 2025 erworben. Laut der erforderlichen Zertifizierung sind dem Verkäufer keine wesentlichen, nicht öffentlichen nachteiligen Informationen bekannt.

Da der geplante Verkauf in Umfang und Anteil am Streubesitz gering ist, wird er voraussichtlich keine wesentlichen Auswirkungen auf die Handelsdynamik haben; dennoch beobachten Investoren Insideraktivitäten oft als Stimmungsindikator.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Small Form 144 indicates limited insider sale; signal value low, structural impact minimal.

The notice covers 13,054 shares, or 0.04 % of outstanding stock, worth under $30k. Coupled with a prior disposal of 5,743 shares earlier this month, the insider appears to be monetising a portion of recently vested RSUs. Such transactions are routine for compensation diversification and do not, by themselves, imply adverse fundamentals. Volume is negligible relative to average daily trading, so price pressure should be immaterial. Nonetheless, continuous selling—if it persists—can affect perception among retail investors in this micro-cap. Absent additional context (10b5-1 plan, executive role), I view the event as neutral in financial significance.

Myomo, Inc. (MYO) – Comunicazione Form 144: Un dirigente ha notificato la vendita di un massimo di 13.054 azioni ordinarie tramite Morgan Stanley Smith Barney. Le azioni hanno un valore complessivo di mercato di 28.588,26 $, pari a circa lo 0,04 % delle 35.978.922 azioni in circolazione della società. La vendita è prevista per il 28 giugno 2025 sulla borsa NYSE American.

La comunicazione riporta anche una vendita precedente effettuata dallo stesso soggetto: 5.743 azioni vendute il 6 giugno 2025 per un ricavo lordo di 17.057 $. Le azioni offerte sono state acquisite tramite il vesting di 40.000 unità di azioni vincolate con data 28 giugno 2025. Secondo la certificazione richiesta, il venditore non è a conoscenza di informazioni riservate rilevanti o negative.

Poiché la vendita proposta è di dimensioni contenute e rappresenta una piccola parte del flottante, è improbabile che influenzi significativamente la dinamica di mercato; tuttavia, gli investitori spesso monitorano l’attività interna come indicatore di sentiment.

Myomo, Inc. (MYO) – Presentación del Formulario 144: Un insider ha notificado la venta de hasta 13.054 acciones comunes a través de Morgan Stanley Smith Barney. Las acciones tienen un valor total de mercado de 28.588,26 $, lo que representa aproximadamente el 0,04 % de las 35.978.922 acciones en circulación de la empresa. La venta está prevista para el 28 junio 2025 en la bolsa NYSE American.

La presentación también revela una venta previa por parte del mismo individuo: 5.743 acciones vendidas el 6 junio 2025 por ingresos brutos de 17.057 $. Las acciones ofrecidas fueron adquiridas mediante el vesting de 40.000 unidades de acciones restringidas con fecha 28 junio 2025. Según la certificación requerida, el declarante no posee información confidencial adversa material.

Dado que la venta propuesta es modesta y representa una pequeña fracción del flotante, es poco probable que tenga un impacto significativo en la dinámica de negociación; sin embargo, los inversores suelen vigilar la actividad interna como señal de sentimiento.

Myomo, Inc. (MYO) – Form 144 제출: 내부자가 Morgan Stanley Smith Barney를 통해 최대 13,054주의 보통주를 매도할 예정임을 신고했습니다. 해당 주식의 총 시장 가치는 28,588.26달러로, 회사의 35,978,922주 유통 주식의 약 0.04 %에 해당합니다. 예정 매도일은 2025년 6월 28일이며, NYSE American 거래소에서 이루어질 예정입니다.

신고서에는 동일인이 이전에 5,743주2025년 6월 6일에 매도하여 총 수익 17,057달러를 올린 사실도 포함되어 있습니다. 매도 예정 주식은 2025년 6월 28일자 제한 주식 단위 40,000주의 베스팅을 통해 취득한 것입니다. 신고자는 요구된 인증에 따라 중대한 비공개 불리한 정보를 알고 있지 않다고 명시했습니다.

제안된 매도 규모가 작고 유통 주식의 일부에 불과하므로 거래 동향에 큰 영향을 미칠 가능성은 낮으나, 투자자들은 내부자 활동을 시장 심리 신호로 자주 주시합니다.

Myomo, Inc. (MYO) – Dépôt du formulaire 144 : Un initié a déposé un avis de vente pouvant atteindre 13 054 actions ordinaires via Morgan Stanley Smith Barney. La valeur totale de ces actions s’élève à 28 588,26 $, soit environ 0,04 % des 35 978 922 actions en circulation de la société. La date prévue de la vente est le 28 juin 2025 sur la bourse NYSE American.

Le dépôt révèle également une vente antérieure par la même personne : 5 743 actions vendues le 6 juin 2025 pour un produit brut de 17 057 $. Les actions proposées ont été acquises par le vesting de 40 000 unités d’actions restreintes daté du 28 juin 2025. Selon la certification requise, le déclarant ne détient aucune information confidentielle défavorable significative.

Étant donné que la vente proposée est modeste en taille et représente une faible fraction du flottant, il est peu probable qu’elle ait un impact significatif sur la dynamique du marché ; cependant, les investisseurs surveillent souvent l’activité des initiés comme indicateur de sentiment.

Myomo, Inc. (MYO) – Form 144 Einreichung: Ein Insider hat den Verkauf von bis zu 13.054 Aktien über Morgan Stanley Smith Barney gemeldet. Der Gesamtwert der Aktien beträgt 28.588,26 $ und entspricht etwa 0,04 % der 35.978.922 ausstehenden Aktien des Unternehmens. Der geplante Verkaufstermin ist der 28. Juni 2025 an der NYSE American Börse.

Die Einreichung offenbart außerdem einen früheren Verkauf derselben Person – 5.743 Aktien wurden am 6. Juni 2025 für Bruttoerlöse von 17.057 $ verkauft. Die angebotenen Aktien wurden durch das Vesting von 40.000 Restricted Stock Units mit Datum 28. Juni 2025 erworben. Laut der erforderlichen Zertifizierung sind dem Verkäufer keine wesentlichen, nicht öffentlichen nachteiligen Informationen bekannt.

Da der geplante Verkauf in Umfang und Anteil am Streubesitz gering ist, wird er voraussichtlich keine wesentlichen Auswirkungen auf die Handelsdynamik haben; dennoch beobachten Investoren Insideraktivitäten oft als Stimmungsindikator.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
NELSON ZACHARY

(Last) (First) (Middle)
C/O PAGERDUTY, INC.
600 TOWNSEND ST., STE. 200

(Street)
SAN FRANCISCO CA 94103

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PagerDuty, Inc. [ PD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/26/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/26/2025 A 12,416(1) A $0 343,067(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents 12,416 Restricted Stock Units acquired pursuant to the Issuer's Non-Employee Director compensation policy. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock of the Issuer and has no expiration date. The shares underlying the Restricted Stock Unit award shall fully vest on the earlier of the first anniversary of the grant date or immediately prior to the next Annual Meeting of stockholders, subject to Directors' continuous service to the Issuer on such date.
2. A portion of these shares represent restricted stock units.
Remarks:
/s/ Irving Gomez, as Attorney-in-Fact, for Zachary Nelson 06/30/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Pagerduty

NYSE:PD

PD Rankings

PD Latest News

PD Latest SEC Filings

PD Stock Data

1.37B
87.12M
7.48%
93.63%
10.73%
Software - Application
Services-prepackaged Software
Link
United States
SAN FRANCISCO